Star Bulk Carriers Corp vs Zimmer Biomet Holdings Inc — how do they compare? Star Bulk Carriers Corp trades at $31.1 (market cap $3.46B), while Zimmer Biomet Holdings Inc trades at $94.73 (market cap $17.97B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 5.2× Star Bulk Carriers Corp's market cap, and Star Bulk Carriers Corp pays the higher dividend (6.06%). Which is the better fit depends on your goals.
| SBLK | ZBH | |
|---|---|---|
Market Cap | $3.46B | $17.97B |
Sector | Industrials | Health |
52-Week High | $32.42 | $104.26 |
52-Week Low | $16.79 | $79.58 |
Enterprise Value | $4.14B | $25.04B |
Dividend Yield | 6.06% | 1.02% |
Signals from Pluang's Aura AI — not financial advice
Star Bulk Carriers (SBLK) trades at $31.02, down 4.32% on the day, with strong technical indicators showing a bullish trend. The company demonstrates robust fundamentals with Q2 2026 EPS of $1.21 beating expectations by 27%, maintaining a three-quarter earnings beat streak. Valuation metrics appear reasonable with P/E of 12.16 and P/B of 1.38, while profitability remains strong with 23.87% net income margin. Recent developments include a parallel listing on Euronext Athens and consistent dividend payments.
SBLK presents a compelling investment case with strong earnings momentum, attractive dividend yield, and positive analyst sentiment. However, risks include shipping rate volatility and geopolitical tensions affecting global trade. The stock's current technical strength and fundamental performance suggest potential upside, though investors should monitor industry cyclicality and the company's execution on its growth strategy.
Zimmer Biomet (ZBH) trades at $94.22, down 3.93% on the day, with a bearish technical signal but strong fundamentals including a 69.87% gross margin and three consecutive quarterly earnings beats. Revenue growth is steady, reaching $8.23B in 2025, though net income margin dipped to 8.56%. Recent leadership promotions aim to accelerate commercial transformation, while analyst consensus price target is $104.88, implying 11.3% upside.
The stock presents a value opportunity with a P/E of 22.87 and P/S of 2.17, supported by robust cash flow and dividend payments. Risks include rising debt-to-asset ratio (32.57% in 2025) and competitive pressures. Wall Street sentiment is mixed with 40.48% buy ratings, but technical indicators suggest near-term caution amid bearish moving averages.
Trailing returns across standard periods
Latest headlines on both assets
Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →